CHBD valuation is cheap by comparison to where the stock and earnings were a year ago ....
Last February the stock traded in a narrow range of $0.87 to $0.95 for the entire month even after reporting $0.00 earnings for September fiscal Q1 and a big loss of ($0.13) for Q2 -
This year the stock is trading only modestly higher on EPS of $0.04 in Q1 and $0.03 in Q2 .... and Q2 is seasonally weak !
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.